Crescendo to present Vectra DA at ACR meeting

Crescendo Biosciences gave four poster presentations showcasing Vectra DA at the American College of Rheumatology (ACR) meeting in Washington D.C. this week.
“Crescendo is pioneering a personalized medicine approach for autoimmune disorders and is committed to helping all patients with rheumatoid arthritis achieve their treatment goals,” Crescendo Biosciences Chief Medical Officer Dr. Elena Hitraya, said. “We are excited about the new data being presented at ACR, including data presented by our collaborators that advance the science of Vectra DA. These findings provide additional information for rheumatologists as they optimize the care of their RA patients.”
More information about Vectra DA can be obtained by visiting the Crescendo booth at the ACR meeting. Vectra DA abstracts can be found at http://acrabstracts.org/meetings/2016-acrarhp-annual-meeting/. Vectra DA can also be followed for more information and news on Twitter at @VectraDA and on Myriad at @MtriadGenetics.